PGEN Latest Headlines

PAPZIMEOS Drives Precigen to Profitability as Revenue More Than Doubles: What the Numbers Reveal

Market Chameleon (Wed, 5-Aug 11:11 AM)

PGEN Achieves Profitability on Accelerating PAPZIMEOS Revenue and Expands US Market Reach

Market Chameleon (Wed, 5-Aug 7:36 AM)

Precigen’s First FDA-Approved Immunotherapy Marks a Turning Point for RRP Patients and Community Advocacy

Market Chameleon (Fri, 12-Jun 10:33 AM)